Abiraterone plus prednisone alone or with dasatinib in chemotherapy-naive metastatic castrate-resistant prostate cancer (mCRPC). Background: Strategies that integrate systemic therapy and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results